Oral Contraceptive Consumption Timing and Cognition and Metabolism
NCT06560944, Not applicable, Completed, University of Lincoln
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Oral Contraceptive Consumption Timing and Cognition and Metabolism | ClinicalTrials.gov |
| NCT number | NCT06560944 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 16 participants, actual | ClinicalTrials.gov |
| Lead sponsor | University of Lincoln | ClinicalTrials.gov |
| Conditions | Cognitive Change | ClinicalTrials.gov |
| Interventions | Combined oral contraceptive pill | ClinicalTrials.gov |
| First posted | 2024-08-19 | ClinicalTrials.gov |
| Last updated | 2024-08-21 | ClinicalTrials.gov |
Registered outcomes 19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Rey Auditory Verbal Test Performance | 60-90 minutes post oral contraceptive/placebo ingestion | Acquisition, Learning rate, Proactive Interference, Retroactive interference, Forgetting | ClinicalTrials.gov |
| Primary | Mental Rotation test | 60-90 minutes post oral contraceptive/placebo ingestion | Accuracy, Response time | ClinicalTrials.gov |
| Primary | Verbal Fluency | 60-90 minutes post oral contraceptive/placebo ingestion | Words said | ClinicalTrials.gov |
| Primary | Stroop test | 60-90 minutes post oral contraceptive/placebo ingestion | Accuracy, Response time | ClinicalTrials.gov |
| Primary | Corsi blocks | 60-90 minutes post oral contraceptive/placebo ingestion | Correct sequences, longest sequence | ClinicalTrials.gov |
| Primary | Rapid Visual Information Processing | 60-90 minutes post oral contraceptive/placebo ingestion | Proportion correct, Response time | ClinicalTrials.gov |
| Primary | Rating of perceived exertion | During final minute of of 6 minutes exercise at both 70 and 90% lactate threshold. Exercise takes place approximately 90 minutes post oral contraceptive/placebo ingestion | Borg rating of perceived exertion (RPE) scale from 6-20. Higher value indicates greater exertion | ClinicalTrials.gov |
| Primary | Felt arousal | During final minute of of 6 minutes exercise at both 70 and 90% lactate threshold. Exercise takes place approximately 90 minutes post oral contraceptive/placebo ingestion | Felt arousal scale from 1-6. Higher value indicates greater level of arousal | ClinicalTrials.gov |
| Primary | Feeling scale | During final minute of of 6 minutes exercise at both 70 and 90% lactate threshold. Exercise takes place approximately 90 minutes post oral contraceptive/placebo ingestion | Feeling scale -5 to +5. Higher value indicates more positive feeling. | ClinicalTrials.gov |
| Primary | Heart rate | During final minute of of 6 minutes exercise at both 70 and 90% lactate threshold. Exercise takes place approximately 90 minutes post oral contraceptive/placebo ingestion | beats per minute | ClinicalTrials.gov |
| Primary | Carbohydrate oxidation | During final minute of of 6 minutes exercise at both 70 and 90% lactate threshold. Exercise takes place approximately 90 minutes post oral contraceptive/placebo ingestion | Rate of carbohydrate use | ClinicalTrials.gov |
| Primary | Fat oxidation | During final minute of of 6 minutes exercise at both 70 and 90% lactate threshold. Exercise takes place approximately 90 minutes post oral contraceptive/placebo ingestion | Rate of fat use | ClinicalTrials.gov |
| Primary | Respiratory exchange ratio | During final minute of of 6 minutes exercise at both 70 and 90% lactate threshold. Exercise takes place approximately 90 minutes post oral contraceptive/placebo ingestion | Ratio of carbohydrate and fat metabolism | ClinicalTrials.gov |
| Primary | Breathing frequency | During final minute of of 6 minutes exercise at both 70 and 90% lactate threshold. Exercise takes place approximately 90 minutes post oral contraceptive/placebo ingestion | breaths per minute | ClinicalTrials.gov |
| Primary | Maximal oxygen consumption (VO2max) | During maximal exercise test which occurs approximately 110 minutes post oral contraceptive/placebo ingestion | Maximal rate of oxygen used | ClinicalTrials.gov |
| Primary | Time to exhaustion | During maximal exercise test which occurs approximately 110 minutes post oral contraceptive/placebo ingestion | Time before test termination | ClinicalTrials.gov |
| Primary | Maximal heart rate | During maximal exercise test which occurs approximately 110 minutes post oral contraceptive/placebo ingestion | Maximal heart rate achieved | ClinicalTrials.gov |
| Secondary | Seum ethinyl estradiol | Baseline and immediately post cognitive function tests | Synthetic oestrogen concentrations in blood | ClinicalTrials.gov |
| Secondary | Serum Levonorgestrel | Baseline and immediately post cognitive function tests | Synthetic progesterone concentrations in blood | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 5
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Corsi Block-Tapping Test | Primary outcome | ConductCognition |
| Mental Rotation | Primary outcome | ConductCognition |
| Rapid Visual Information Processing | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Verbal Fluency | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)